Biofrontera AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other
pharmaceutical manufacturers in Europe:
Celon Pharma SA
sales of 139.27 million Polish New Zlotys [US$37.91 million]
(336.00 million Swedish Kronor [US$40.66 million]
of which 96%
was Sales of development related goods and s), and
Circassia Group PLC
based in UNITED KINGDOM
(£23.90 million [US$33.76 million]
of which 100%
During the first
quarter of 2021, sales at Biofrontera AG totalled
5.48 million Euro.
This is a drop of 15.4%
from the 6.47 million Euro in sales at the company during the first quarter in 2020.
Biofrontera AG reported sales of 30.35 million Euro (US$36.96 million)
December of 2020.
decrease of 2.9%
versus 2019, when the company's sales were 31.27 million Euro.